Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate Trial
This means the company managed to recruit a few thousand phase 3 trial participants over the last week or so.
Full Article
Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate Trial
Motley Fool
0 shares
1 views
You might like
Related news coverage
Wall Street overcomes early deficits to finish the week strong
Proactive Investors
4pm: Wall Street finishes in positive territory The Dow Jones Industrial Average closed up 191 points, or 0.7%, to 27,931,..
-
US stocks still heading north as Apple climbs towards new high
Proactive Investors
-
US stocks still up as Apple climbs towards new high
Proactive Investors
-
US benchmarks higher as traders welcome home sales report: Pfizer in focus
Proactive Investors
-
Wall Street shares higher but FTSE 100 closes down
Proactive Investors
Advertisement
More coverage
-
Wall Street set for subdued start
Proactive Investors
-
Pfizer coronavirus vaccine passes early stage trials
Proactive Investors